A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

Clinical trial NCT07256782 · RECRUITING

Trial details

NCT number: NCT07256782
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-10-24
Primary completion: 2026-10-01
Enrollment: 444

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.